John Sturdivant, MD
Clinical Cardiac Electrophysiology · Myrtle Beach, SCNPI 1700994662
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $39,219 of the $58,344 with a category attached, or 67.2%. Boston Scientific accounts for 76.4% of it on its own, with 22 other manufacturers making up the rest. 2025 is the largest year on record at $41,122, more than ten times the $614 reported in 2019.
Across 317 payments — averaging $184.05 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Boston Scientific$45K
- Abbott$6K
- Medtronic$5K
- Cvrx, Inc.$615
- ZOLL Respicardia, Inc.$370
- Atricure, Inc.$368
- plus $982 from 17 others
Across 23 payments — averaging $3475.22 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Boston Scientific$80K
- Abbott$228
What the payments were for
- Speaking & faculty fees$39,21967%
- Travel & lodging$8,45714%
- Food & beverage$10,66818%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Boston Scientific | 109 | $44,595 |
| Abbott | 69 | $6,115 |
| Medtronic(2 entities) | 78 | $5,298 |
| Cvrx, Inc. | 8 | $615 |
| ZOLL Respicardia, Inc. | 1 | $370 |
| Atricure, Inc. | 6 | $368 |
| Cardiva Medical, Inc. | 13 | $267 |
| Pfizer | 6 | $124 |
| Biosense Webster, Inc. | 3 | $92 |
| E.r. Squibb & Sons, L.L.C. | 3 | $89 |
| Alnylam Pharmaceuticals Inc. | 4 | $84 |
| Amgen | 3 | $46 |
| Cordis US CORP. | 2 | $44 |
| Baxter Healthcare | 2 | $36 |
| Inspire Medical Systems, Inc. | 1 | $31 |
| Novo Nordisk | 1 | $31 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 2 | $31 |
| Scpharmaceuticals Inc. | 1 | $26 |
| Irhythm Technologies, Inc. | 1 | $20 |
| Novartis | 1 | $17 |
| Boehringer Ingelheim | 1 | $16 |
| Johnson & Johnson | 1 | $15 |
| AbbVie | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- GENERAL EP$39,219
- AMPLATZER AMULET$2,620
- AVEIR$2,059
- SelectSecure$1,170
- COBALT DR MRI SURESCAN$830
- Barostim Neo System$559
- WATCHMAN Access System$558
- remede System$370
- Cobalt$349
- WATCHMAN FLX$285
- Arctic Front$247
- Micra$244
- EPI-SENSE GUIDED COAGULATION SYSTEM WITH VISITRAX$165
- Rhythmia Mapping System$153
- ARCTIC FRONT ADVANCE$143
How this compares
$58,344 in reported general payments places this provider in the 65th percentile of 58 clinical cardiac electrophysiology providers in South Carolina.
See all clinical cardiac electrophysiology providers in South Carolina →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 262 | $260,952 |
| XareltoRivaroxaban | 41 | $55,119 |
| EntrestoSacubitril/Valsartan | 23 | $39,582 |
| MultaqDronedarone Hcl | 16 | $11,755 |
| Flecainide Acetate | 58 | $3,742 |
| Dofetilide | 12 | $3,393 |
| Metoprolol Succinate | 170 | $2,658 |
| Amiodarone Hcl | 183 | $2,440 |
| Diltiazem 24hr Er (La)Diltiazem Hcl | 16 | $1,508 |
| Dilt-XrDiltiazem Hcl | 23 | $907 |
| Spironolactone | 70 | $616 |
| Diltiazem 24hr Er (Cd)Diltiazem Hcl | 19 | $609 |
| Metoprolol Tartrate | 85 | $477 |
| Lisinopril | 38 | $307 |
| Losartan Potassium | 39 | $295 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerEliquis | $124 | $260,952262 claims |
| Johnson & JohnsonXarelto | $15 | $55,11941 claims |
| NovartisEntresto | $17 | $39,58223 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 65th percentile of 58 clinical cardiac electrophysiology providers in South Carolina.
Other clinical cardiac electrophysiology in Myrtle Beach
- Jason GoebelMyrtle Beach$7K
- Jeffrey WinterfieldCharleston$498K
- Frank CuocoCharleston$306K
- Anne KromanCharleston$279K
- Andrew BrenyoRock Hill$241K
- Joseph ManfrediGreenville$213K
- Michael GoldCharleston$204K
- Sultan SiddiqueColumbia$182K
- Peter NetzlerGreenville$146K
- Yuxuan MaoLittle River$126K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.